⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TVRD News
Tvardi Therapeutics, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD
accessnewswire.com
TVRD
Ongoing Securities Investigation Into Tvardi Therapeutics, Inc. (TVRD) - Contact Levi & Korsinsky
accessnewswire.com
TVRD
Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update
businesswire.com
TVRD
Tvardi Therapeutics, Inc. (TVRD) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today
accessnewswire.com
TVRD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD
accessnewswire.com
TVRD
Investigation Opened on Behalf of Tvardi Therapeutics, Inc. (TVRD) Shareholders - Contact Levi & Korsinsky
accessnewswire.com
TVRD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD
accessnewswire.com
TVRD
Levi & Korsinsky Investigating Whether Tvardi Therapeutics, Inc. (TVRD) Misled Investors - Securities Law Violations Possible
accessnewswire.com
TVRD
ATTENTION TVRD Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
accessnewswire.com
TVRD
Tvardi Therapeutics, Inc. (TVRD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
TVRD